Analyst Juan Avendano is covering the the Healthcare sector with 20 price targets and ratings documented since 2017 spanning on 2 stocks.
Juan Avendano's average stock forecast success ratio is 90% with an average time for price targets to be met of 52.5 days.
Most recent stock forecast was given on CRL, Charles River Laboratories International, Inc at 05-Aug-2021.
Analyst best performing recommendations are on CRL (CHARLES RIVER LABORATORIES INTERNATIONAL, INC).
The best stock recommendation documented was for CRL (CHARLES RIVER LABORATORIES INTERNATIONAL, INC) at 7/1/2020. The price target of $192 was fulfilled within 14 days with a profit of $16.44 (9.36%) receiving and performance score of 6.69.
Average potential price target upside
Currently, out of the existing stock ratings of Juan Avendano - 111 which are a Hold (28.46%), 74 which are a Sell (18.97%), 205 which are a Buy (52.56%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
400
$65.37 (19.54%)
340
1 months 21 days ago
3/4 (75%)
$26.55 (8.44%)
57
Buy
375
$40.37 (12.06%)
315
3 months 15 days ago
5/8 (62.5%)
$64.3 (28.69%)
182
Buy
250
$-84.63 (-25.29%)
280
7 months 4 days ago
5/5 (100%)
$13.84 (10.92%)
95
Buy
280
$58.49 (26.41%)
200
2 years 10 months 11 days ago
3/3 (100%)
$7.77 (2.29%)
51
Buy
122
$-212.63 (-63.54%)
115
4 years 1 months ago
8/9 (88.89%)
$3.37 (4.31%)
82
